{"id":"npc-15","safety":{"commonSideEffects":[{"rate":"null","effect":"Increased risk of genital yeast infections"}]},"_chembl":{"chemblId":"CHEMBL2372276","moleculeType":"Protein","molecularWeight":"1363.59"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"NPC-15 works by inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys, reducing glucose reabsorption and lowering blood glucose levels. This mechanism is particularly effective in treating type 2 diabetes.","oneSentence":"NPC-15 is a small molecule that targets the SGLT2 receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:50:29.522Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT02757079","phase":"PHASE3","title":"Study of the Efficacy and Safety of NPC-15 for Sleep Disorders of Children With Neurodevelopmental Disorders","status":"COMPLETED","sponsor":"Nobelpharma","startDate":"2016-06-21","conditions":"Sleep Disorders, Neurodevelopmental Disorder","enrollment":99},{"nctId":"NCT02757066","phase":"PHASE2, PHASE3","title":"Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum Disorders","status":"COMPLETED","sponsor":"Nobelpharma","startDate":"2016-06-16","conditions":"Sleep Disorders, Autism Spectrum Disorder","enrollment":196},{"nctId":"NCT03475459","phase":"PHASE1","title":"Investigation of Arrhythmogenic Effect of NPC-15 (NPC-15-7)","status":"COMPLETED","sponsor":"Nobelpharma","startDate":"2018-04-03","conditions":"Qt Interval, Variation in","enrollment":12}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Melatonin"],"phase":"phase_3","status":"active","brandName":"NPC-15","genericName":"NPC-15","companyName":"Nobelpharma","companyId":"nobelpharma","modality":"Small molecule","firstApprovalDate":"","aiSummary":"NPC-15 is a small molecule that targets the SGLT2 receptor. Used for Treatment of type 2 diabetes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}